Effects of Unfractionated Heparin or Low-Molecular-Weight Heparin for Preventing Thrombosis after Infrainguinal Arterial Bypass ProceduresEmile Calenda1*, Nolwenn Minguy1, Eric Danielou1, Nathalie David2, Bertrand Dureuil1 and Didier Plissonnier2
- *Corresponding Author:
- Emile Calenda
Department of Anesthesiology
Rouen University Hospital Institute for Biomedical Research
76031 Rouen cedex, France, Europe
E-mail: [email protected]
Received Date: April 27, 2016; Accepted Date: December 22, 2016; Published Date: December 29, 2016
Citation: Calenda E, Minguy N, Danielou E, David N, Dureuil B, et al. (2016) Effects of Unfractionated Heparin or Low-Molecular-Weight Heparin for Preventing Thrombosis after Infrainguinal Arterial Bypass Procedures. J Vasc Med Surg 4: 296. doi: 10.4172/2329-6925.1000296
Copyright: © 2016 Calenda E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Unfractionated heparin or low-molecular-weight heparin for preventing thrombosis after infrainguinal arterial bypass procedures are commonly used without validation. We decided to assess both attitudes with the help of a retrospective study. We reported a non-inferiority between low-molecular-weight heparin and unfractionated heparin. It is possible to use unfractionated heparin in case of renal failure and a low molecular weight heparin when the clearance is normal because both therapies are equivalent.